In recent years, a popular cannabis compound has exploded onto the consumer market, demanding an ever-increasing awareness of the drug by industrialists and politicians, alike. This organic compound is known as CBD, or cannabidiol, and is also commonly found in the non-psychoactive industrial hemp plant that has been grown for millennia as a staple for both food and fiber supply.
As cottage industries that have sprouted up around the non-psychoactive hemp compound have started to flourish, they've attracted the attention of wealthy investors - the least of which is the multi-trillion-dollar pharmaceutical industry, who seems to have recognized what they have to gain (or lose) with the popularity of such an over-the-counter product.
The value of industrial hemp is nothing short of unbelievable. I remember the first time I came across the information in college and literally thought it must just be some sort of stoner propaganda. Hemp seeds alone have saved cultures from famine, as the seeds contain everything the human body needs to survive (it's not the only plant with that range of nutrition, but, come on). Furthermore, it is the strongest natural fiber on the planet as well as the hottest-burning, making it ideal as a fuel source as well as a fiber for cloth or rope.
As a fabric, it's so diverse that it can be manufactured into such aesthetically fine products as silk but was also the only appropriate material before synthetics to make strong ship sails from that naturally resisted rotting. As such, bizarrely enough, Hemp was a mandatory plant to grow in the earliest colonies of the United States and citizens could pay their taxes in the stalks.
According to the Non-GMO Report, Hemp production in the United States increased 163% between the years of 2016 and 2017 alone, and Brightfield Group predicts a 40-fold increase in the industry in just the next four years.
With speculations like these, it's no wonder pharmaceutical companies have become interested in the product.
Epidiolex, a CBD-based, hemp-derived product developed and marketed by GW Pharmaceuticals has now been approved for sale across all 50 states. At the same time, it seems, Federal organizations are pulling to diminish the rights to sell similar products away from smaller manufacturers.
Senate Majority Leader Mitch McConnell (the one with the big neck pouch that makes him look like a turtle or, more accurately an Italian Tree Frog) has been pushing for a change in hemp legislation since 2013.
Like the Italian Tree Frog, McConnell has used his enlarged vocal sack to amplify a rallying call to fellow industrialists and politicians. This mating vocalization, as it were, collimated in the most recent election with a ballot initiative labeled in Colorado as Amendment X.
Well, that's how it was generally advertised, and it passed. It's really just up to how the Trump White House treats the issue, though I'm not particularly hopeful.
There was a fervor of spectacular news reports just before the election insisting on the importance of such a bill. To their credit, I have to cite Westword in seeming to be the only objective narrative I'd come across on the subject.
Thanks for caring, Rob Corry.
It's a little confusing. In general, Cannabis and Industrial Hemp have always been seen federally, as the same plant, even though industrial Hemp has no potential of getting anybody stoned. Colorado had redefined industrial Hemp with Amendment 64 to differentiate it from the psychoactive plants we all know as Cannabis. Industrial Hemp is great for ropes and fuel, silk and plastic even, but not at all good for smoking. This allowed for industrial Hemp manufacturers to be free of the same type of scrutiny that might be allotted to a major cannabis supplier like a grow house for a dispensary.
In fact, when amendment 64 was passed about 10 years ago, now, the industry for CBD products have not even gotten off foot. It seems apparent that the legislature passed through Amendment X is a corporate response to the overwhelming increase of popularity for hemp-derived, non-psychoactive CBD products. What it boils down to, is that legalized states like Colorado have written into their constitution, and had passed democratically, amendments redefining the plants to protect both Hemp and Cannabis industries from unnecessary scrutiny and control.
What Amendment X does, is erase that defining line, and lump non-psychoactive Hemp back into the same - entirely prohibited - category as Cannabis under Federal jurisdiction. Let's not forget that as popular as cannabis legalization becomes, the plant has still yet to be recognized as even medicinally valuable by federal standards and is somehow still classified into the same legal categories as heroin and all the other most deadly street substances. “Schedule 1” means “no medical value” and that's why declassifying cannabis at the federal level remains a top priority amongst activists.
Fortunately, there's a growing amount of credible information to discredit that hundred-year old propaganda. One positive thing about Amendment X is that it should expand the potential to study the plants, even in University settings.
CBD is one of the hottest products on the market right now, with Innovations continuing to pop out of nowhere in formats that no one could expect. CBD soda or CBD infused sparkling water has just recently hit the market and has taken off running along with the sparkling water craze of recent years. CBD infused soda is also reaching heights along with a myriad of other cannabidiol-infused products from gummy bears to dog treats.